Italia markets close in 3 hours 35 minutes

SWTX Dec 2024 60.000 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
3,00000,0000 (0,00%)
In data: 12:52PM EDT. Mercato aperto.
Schermo intero
Chiusura precedente3,0000
ApertoN/D
Denaro1,0500
Domanda5,0000
Prezzo d'esercizio60,00
Scadenza2024-12-20
Min-Max giorno3,0000 - 3,0000
Contratto - Min-MaxN/D
VolumeN/D
Open Interest1
  • GlobeNewswire

    SpringWorks Therapeutics Reports Second Quarter 2023 Financial Results and Recent Business Highlights

    – Presented additional Phase 3 DeFi data at ASCO demonstrating clinically significant reductions in pain and substantial reductions in tumor volume and T2 hyperintensity with nirogacestat treatment – – Completed enrollment of Phase 2 trial evaluating nirogacestat in patients with ovarian granulosa cell tumors – – Highlighted encouraging Phase 1 and 2 clinical data from emerging pipeline programs at AACR and EHA – STAMFORD, Conn., Aug. 02, 2023 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (